Matrix Laboratories Limited is pleased to announce the appointment of Dr. B Gopalan as Chief Scientific Officer (CSO). A doctorate in Synthetic Organic Chemistry from University of Madras, Dr. Gopalan brings with him 30 years of rich experience in R&D to Matrix. Dr Gopalan has 25 worldwide patents and several publications to his credit.

Dr. Gopalan did 2 years of post-doctoral work at Harvard University with Professor E J Corey (Nobel Laureate). In the US, he worked with Syntex Research, California, and Bristol Meyers Squibb. In India, he was associated with Boots Pharma, Sun Pharma, Glaxo and Merck.

Before joining Matrix, Dr. Gopalan was associated with Glenmark Pharmaceuticals as Senior Vice President (Chemical Research). During his five-year tenure with Glenmark, Dr. Gopalan was in-charge of Drug Discovery Chemistry Research in the therapeutic segments of diabetes, obesity and PhosphoDiEsterase 4- Inhibitors.

Dr. Gopalan's appointment emphasizes the Matrix's commitment to building a strong scientific team. His rich experience in R&D will enhance the scientific capabilities and foster the innovation efforts of Matrix.